Found: 22
Select item for more details and to access through your institution.
Steroid-Unresponsive Acute Attacks of Inflammatory Bowel Disease: Immunomodulation by Tacrolimus (FK506).
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 10, p. 1860, doi. 10.1111/j.1572-0241.1998.539_g.x
- By:
- Publication type:
- Article
ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 422, doi. 10.1038/clpt.2010.348
- By:
- Publication type:
- Article
Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans.
- Published in:
- Mucosal Immunology (1933-0219), 2009, v. 2, n. 2, p. 166, doi. 10.1038/mi.2008.77
- By:
- Publication type:
- Article
Inflammatory bowel diseases influence major histocompatibility complex class I ( MHC I) and II compartments in intestinal epithelial cells.
- Published in:
- Clinical & Experimental Immunology, 2013, v. 172, n. 2, p. 280, doi. 10.1111/cei.12047
- By:
- Publication type:
- Article
Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2.
- Published in:
- Clinical & Experimental Immunology, 2008, v. 151, n. 3, p. 528, doi. 10.1111/j.1365-2249.2007.03587.x
- By:
- Publication type:
- Article
Limited Heat-Shock Protein 72 Induction in Caco-2 Cells by L-Glutamine.
- Published in:
- Digestion, 2001, v. 64, n. 2, p. 81, doi. 10.1159/000048844
- By:
- Publication type:
- Article
O0033 THE PROBIOTIC STRAIN E. COLI NISSLE 1917 INDUCES HUMAN BETA DEFENSIN-2 BY A NF-k-B DEPENDENT MECHANISM IN CACO-2 CELLS.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 2004, v. 39, p. S20, doi. 10.1097/00005176-200406001-00035
- By:
- Publication type:
- Article
Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2004, v. 19, n. 12, p. 1269, doi. 10.1111/j.1365-2036.2004.01947.x
- By:
- Publication type:
- Article
Remission maintenance by tioguanine in chronic active Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 17, n. 12, p. 1459, doi. 10.1046/j.1365-2036.2003.01590.x
- By:
- Publication type:
- Article
6-Thioguanine — efficacy and safety in chronic active Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 17, n. 4, p. 503, doi. 10.1046/j.1365-2036.2003.01440.x
- By:
- Publication type:
- Article
Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2001, v. 15, n. 3, p. 363, doi. 10.1046/j.1365-2036.2001.00940.x
- By:
- Publication type:
- Article
Therapie chronisch-entzündlicher Darmerkrankungen.
- Published in:
- Der Internist, 2014, v. 55, n. 8, p. 906, doi. 10.1007/s00108-013-3442-1
- By:
- Publication type:
- Article
Intensivmedizin und chronisch entzündliche Darmerkrankungen (CED).
- Published in:
- Der Internist, 2011, v. 52, n. 7, p. 833, doi. 10.1007/s00108-010-2797-9
- By:
- Publication type:
- Article
Standardtherapie der Colitis ulcerosa.
- Published in:
- Der Internist, 2002, v. 43, n. 11, p. 1367, doi. 10.1007/s00108-002-0709-3
- By:
- Publication type:
- Article
Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 581, doi. 10.1111/apt.14479
- By:
- Publication type:
- Article
Letter: short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 4, p. 502, doi. 10.1111/apt.12214
- By:
- Publication type:
- Article
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 1, p. 129, doi. 10.1111/apt.12118
- By:
- Publication type:
- Article
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 9, p. 1036, doi. 10.1111/j.1365-2036.2010.04267.x
- By:
- Publication type:
- Article
Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn’s disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 6, p. 621, doi. 10.1111/j.1365-2036.2009.04070.x
- By:
- Publication type:
- Article
Clinical trial: cyclophosphamide pulse therapy – a promising therapeutic alternative in refractory Crohn’s disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 29, n. 12, p. 1230, doi. 10.1111/j.1365-2036.2009.03999.x
- By:
- Publication type:
- Article
Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 1, p. 31, doi. 10.1093/ecco-jcc/jjv175
- By:
- Publication type:
- Article
ATL>Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2002, v. 97, n. 2, p. 377, doi. 10.1111/j.1572-0241.2002.05473.x
- By:
- Publication type:
- Article